Advanced Medical Solutions Group (AMS) Share Price, News & Analysis

Company Overview

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and hernia mesh fixation device that allows for the accurate laparoscopic internal application of its cyanoacrylate adhesive to attach hernia meshes under the LiquiBandFix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobials, and hydrocolloids, as well as wound care products under the ActivHeal brand, as well as under white-label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.

Key Stats

• Today's Range: 189.40 to 197.40
• 50-Day Range: 191.80 to 239.50
• 52-Week Range: 176.60 to 275.83
• Volume: 255,764 shs
• Average Volume: 456,832 shs
• Market Capitalization: £420.52 million
• P/E Ratio: 3,920.00
• Dividend Yield: 1.02%
• Price Target: GBX 300
• Consensus Rating: Buy

Advanced Medical Solutions Group Stock Analysis - MarketRank™

Advanced Medical Solutions Group scored higher than 34% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Advanced Medical Solutions Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Advanced Medical Solutions Group has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Advanced Medical Solutions Group is 3,920.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 115.09.

Price to Earnings Ratio vs. Sector

The P/E ratio of Advanced Medical Solutions Group is 3,920.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 91.34.

Price to Earnings Growth Ratio

Advanced Medical Solutions Group has a PEG Ratio of 5.00. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Advanced Medical Solutions Group has a P/B Ratio of 1.73. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for AMS.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Advanced Medical Solutions Group pays a meaningful dividend of 1.17%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Advanced Medical Solutions Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Advanced Medical Solutions Group is 4,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for AMS.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

5 people have searched for AMS on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Advanced Medical Solutions Group insiders have bought 34.22% more of their company's stock than they have sold. Specifically, they have bought £100,171.20 in company stock and sold £74,632.30 in company stock.

Percentage Held by Insiders

Only 3.12% of the stock of Advanced Medical Solutions Group is held by insiders.

Percentage Held by Institutions

58.24% of the stock of Advanced Medical Solutions Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

AMS Stock Analysis - Frequently Asked Questions

How have AMS shares performed this year?

Advanced Medical Solutions Group's stock was trading at GBX 207.50 at the beginning of the year. Since then, AMS stock has decreased by 5.5% and is now trading at GBX 196.
View the best growth stocks for 2024 here.

How do I buy shares of Advanced Medical Solutions Group?

Shares of AMS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Advanced Medical Solutions Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Medical Solutions Group investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Athabasca Oil (ATH), AutoZone (AZO), Chipotle Mexican Grill (CMG) and Micron Technology (MU).

Company Calendar

• Ex-Dividend for 10/25 Dividend: 9/26/2024
• Dividend Payable: 10/25/2024
• Today: 12/21/2024

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: Healthcare
• Current Symbol: LON:AMS
• CUSIP: N/A
• CIK: N/A
• Web: www.admedsol.com
• Phone: +44-1606-863500
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: GBX 300
• High Stock Price Target: GBX 300
• Low Stock Price Target: GBX 300
• Potential Upside/Downside: +53.1%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): GBX 0.05
• Trailing P/E Ratio: 3,920.00
• Forward P/E Ratio: 19.97
• P/E Growth: 5
• Net Income: £11.13 million
• Net Margins: 8.49%
• Pretax Margin: N/A
• Return on Equity: 4.59%
• Return on Assets: 2.35%

Debt

• Debt-to-Equity Ratio: 37.01
• Current Ratio: 8.39
• Quick Ratio: 4.58

Sales & Book Value

• Annual Sales: £131.11 million
• Price / Sales: 3.21
• Cash Flow: GBX 24.89 per share
• Price / Cash Flow: 7.87
• Book Value: GBX 113 per share
• Price / Book: 1.73

Miscellaneous

• Outstanding Shares: 214,550,000
• Free Float: N/A
• Market Cap: £420.52 million
• Optionable: Not Optionable
• Beta: 0.74